MENU
FDMT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
4D Molecular Therapeutics (FDMT) Ownership - Who owns 4D Molecular Therapeutics?
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors... Show more
Profile
Industry
N/A
Address
5858 Horton Street
Phone
+1 510 505-2680
Employees
147
Web
https://www.4dmoleculartherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
181.13M
P/E Ratio
N/A
Total Cash
321.44M
Projected Growth
N/A
Total Debt
23.85M
Revenue
23K
Risk (Beta)
3.31
Dividend Yield
N/A
Total Cash/Share
6.94
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price
Fundamentals
FDMT
Capitalization
181M
P/E Ratio
N/A
Risk (Beta)
3.31
Dividend Yield
N/A
Total Cash
321M
Total Cash/Share
6.94
Total Debt
23.9M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.00%
Revenue
23K
ROE
N/A
Book Value
470M
P/B Ratio
0.38
Cash Flow
N/A
Earnings
-3.18
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
12.36
Current Revenue Per Employee
61.67
Dividends Per Share - Security
N/A
EBITDA
-196.46M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-30.80
Shares Held By Institutions
378M
Shares Outstanding - Current
46.3M
Total Liabilities
46M
Total Volume MTD
N/A
Value
-1
Gain YTD
-29.803
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
5858 Horton Street
Phone
+1 510 505-2680
Employees
147
Web
https://www.4dmoleculartherapeutics.com